News

New Kaiser Permanente research shows that the COVID-19 vaccine does not increase the risk of developing tinnitus, which is a ringing in the ears. “Early on in the COVID-19 pandemic, some people complained about hearing some sound after being vaccinated, but it wasn’t actually an external sound, it was tinnitus, which is the perception of sound ...

A new Kaiser Permanente study showed that fewer breast cancer survivors received recommended annual breast cancer imaging in the time after the COVID-19 pandemic period compared to before the pandemic. The study was published in JAMA Oncology in July 2025. Little has been known previously about the impact of the COVID-19 pandemic on post-treatment surveillance for ...

A diagnosis of Type 2 diabetes typically means a future of blood sugar monitoring and glucose-lowering medications. But interest is growing in identifying which people with diabetes might be able to stop taking their medications and control their disease with diet and exercise alone. A new Kaiser Permanente study, published in Diabetes Care, sheds light ...

A behavioral and public health scientist, Taynara Formagini, PhD, MSc, is a postdoctoral research fellow in the Department of Research & Evaluation. Her work focuses on preventing cardiovascular and chronic diseases among racial and ethnic minorities and socioeconomically disadvantaged populations through a combination of intervention research and epidemiology. What inspired you to pursue research? I’m a first-generation ...

Kaiser Permanente research found that breast cancer survivors have a higher risk of developing other cancers if they have other preexisting health conditions, such as high blood pressure and diabetes. “Preexisting health conditions are common in people diagnosed with cancer and what we’ve learned with this study is that comorbidities — experiencing multiple illnesses or disorders ...

Maheen Humayun, PhD, MPH, is an infectious disease epidemiologist and postdoctoral research fellow in the Department of Research & Evaluation. Prior to joining Kaiser Permanente, Dr. Humayun worked as an HIV Cluster Detection and Response Fellow at the Centers for Disease Control and Prevention. In that role, she analyzed national HIV surveillance data to detect rapid ...

About 16% of breast cancer survivors continued to use opioid pain medications after their cancer treatment was complete, a new Kaiser Permanente study showed. The study also found that risk of death was 84% higher among these survivors who continued to use opioids. The study was published in June 2025 in JNCI Cancer Spectrum. “The most important ...

Growing numbers of patients are diagnosed with cancer between the ages of 15 and 39. These younger cancer patients can have complex health needs after their cancer treatment and should receive health care that includes screening for new cancers, addresses potential issues related to their treatment, and emphasizes general preventive care. Researchers at Kaiser Permanente Southern ...